GSK-Pfizer deal gets approval from Australia's anti-trust watchdog

France Nouvelles Nouvelles

GSK-Pfizer deal gets approval from Australia's anti-trust watchdog
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 97%

GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business wi...

FILE PHOTO: The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo

The two pharmaceutical giants in December said they would combine their consumer health businesses in a joint venture that would be 68 percent-owned by GSK.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
Lire la suite »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
Lire la suite »

Pfizer gets U.S. approval for $225,000 a year heart drugPfizer gets U.S. approval for $225,000 a year heart drugThe U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral ...
Lire la suite »

Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItInsurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItPfizer won U.S. approval for its drug tafamidis to treat a rare heart disease, but whether the treatment that costs $225,000 year will be covered by heath insurers and employers remains unclear
Lire la suite »

Pfizer gets U.S. approval for $225,000 a year heart drugPfizer gets U.S. approval for $225,000 a year heart drugThe U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral ...
Lire la suite »

Sanofi’s Dengue Vaccine Gets FDA ApprovalSanofi’s Dengue Vaccine Gets FDA ApprovalSanofi dengue vaccine was approved in the U.S., the first treatment cleared by American regulators to protect against the mosquito-borne viral infection.
Lire la suite »

A Formerly Anti-Vax Mom Posted Why Her Kids Are Getting VaccinatedA Formerly Anti-Vax Mom Posted Why Her Kids Are Getting VaccinatedA Mom Who Grew Up Unvaccinated Said She's Now 'Proud To Vaccinate' Her Own Kids
Lire la suite »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
Lire la suite »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
Lire la suite »

Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItInsurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItPfizer won U.S. approval for its drug tafamidis to treat a rare heart disease, but whether the treatment that costs $225,000 year will be covered by heath insurers and employers remains unclear
Lire la suite »

CNN Poll: Trump's approval rating on the economy hits a new highCNN Poll: Trump's approval rating on the economy hits a new highPresident Donald Trump hits a new high on his economic approval ratings in a new CNN Poll conducted by SSRS, reaching 56% of Americans saying he's doing a good job on the economy.
Lire la suite »



Render Time: 2025-03-10 03:45:56